Total Payments
$6,134
2022 Payments
$764.91
Companies
6
Transactions
19
Medicare Patients
752
Medicare Billing
$81,997
Payment Breakdown by Category
Consulting$3,550 (57.9%)
Travel$1,679 (27.4%)
Research$475.00 (7.7%)
Food & Beverage$430.46 (7.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,550 | 5 | 57.9% |
| Travel and Lodging | $1,679 | 5 | 27.4% |
| Unspecified | $475.00 | 1 | 7.7% |
| Food and Beverage | $430.46 | 8 | 7.0% |
Payments by Type
General
$5,659
18 transactions
Research
$475.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $2,550 | 4 | $0 (2020) |
| Kyowa Hakko Kirin Co., Ltd | $1,108 | 3 | $0 (2019) |
| Boehringer Ingelheim International GmbH | $1,068 | 7 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $764.91 | 2 | $0 (2022) |
| Eli Lilly and Company | $475.00 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $168.56 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $764.91 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($764.91) |
| 2020 | $2,550 | 4 | AKEBIA THERAPEUTICS INC ($2,550) |
| 2019 | $2,345 | 12 | Kyowa Hakko Kirin Co., Ltd ($1,108) |
| 2018 | $475.00 | 1 | Eli Lilly and Company ($475.00) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $757.20 | General |
| Category: DIABETES | ||||||
| 11/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: DIABETES | ||||||
| 08/05/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: NEPHROLOGY | ||||||
| 06/03/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: NEPHROLOGY | ||||||
| 05/05/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: NEPHROLOGY | ||||||
| 04/07/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/25/2019 | Kyowa Hakko Kirin Co., Ltd | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/25/2019 | Kyowa Hakko Kirin Co., Ltd | — | Food and Beverage | In-kind items and services | $101.04 | General |
| 11/25/2019 | Kyowa Hakko Kirin Co., Ltd | — | Travel and Lodging | Cash or cash equivalent | $7.00 | General |
| 10/03/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $127.52 | General |
| 10/03/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $41.04 | General |
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $437.41 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $274.18 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $203.18 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $70.52 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Boehringer Ingelheim International GmbH | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: DIABETES | ||||||
| 10/23/2018 | Eli Lilly and Company | — | — | Cash or cash equivalent | $475.00 | Research |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 121 | 157 | $53,023 | $14,181 |
| 2022 | 6 | 195 | 290 | $86,046 | $20,188 |
| 2021 | 7 | 268 | 395 | $119,067 | $28,515 |
| 2020 | 7 | 168 | 250 | $76,612 | $19,113 |
Total Patients
752
Total Services
1,092
Medicare Billing
$81,997
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 58 | $18,734 | $5,688 | 30.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 41 | $8,897 | $2,774 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $12,325 | $2,570 | 20.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 22 | $6,842 | $2,239 | 32.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 13 | 15 | $6,225 | $911.70 | 14.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 68 | 132 | $28,668 | $7,935 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 45 | $14,535 | $3,786 | 26.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 34 | 49 | $20,335 | $3,037 | 14.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 24 | $7,464 | $2,095 | 28.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 22 | 23 | $8,142 | $2,012 | 24.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $6,902 | $1,323 | 19.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 87 | 140 | $30,380 | $8,628 | 28.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 45 | 78 | $24,258 | $6,901 | 28.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 55 | 84 | $34,860 | $5,249 | 15.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 40 | $12,920 | $3,654 | 28.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 30 | 30 | $10,620 | $2,645 | 24.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $4,720 | $1,077 | 22.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 11 | $1,309 | $360.91 | 27.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 35 | 64 | $19,904 | $5,598 | 28.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 70 | $15,190 | $4,296 | 28.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 30 | $9,690 | $2,668 | 27.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 29 | 44 | $18,260 | $2,637 | 14.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 18 | $4,500 | $1,702 | 37.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 13 | 13 | $4,602 | $1,180 | 25.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $4,466 | $1,031 | 23.1% |
About Dr. Tamara Isakova, MD
Dr. Tamara Isakova, MD is a Nephrology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902879778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tamara Isakova, MD has received a total of $6,134 in payments from pharmaceutical and medical device companies, with $764.91 received in 2022. These payments were reported across 19 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($3,550).
As a Medicare-enrolled provider, Isakova has provided services to 752 Medicare beneficiaries, totaling 1,092 services with total Medicare billing of $81,997. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Chicago, IL
- Active Since 02/10/2006
- Last Updated 09/30/2013
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1902879778
Products in Payments
- AURYXIA (Drug) $2,550
- JARDIANCE (Drug) $1,833
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chicago
Nicole Stankus
Nephrology — Payments: $241,812
Nephrology $241,812
Susan Quaggin, Md, MD
Nephrology — Payments: $235,919
Nephrology $235,919
Lorenzo Gallon, Md, MD
Nephrology — Payments: $187,956
Nephrology $187,956
John Friedewald, Md, MD
Nephrology — Payments: $131,619
Nephrology $131,619
Arlene Chapman
Nephrology — Payments: $125,467
Nephrology $125,467
Dr. Jay Koyner, M.d, M.D
Nephrology — Payments: $87,521
Nephrology $87,521